V
Power Law company profile
Ventyx Biosciences
Biotech & Life Sciences · Encinitas, United States · Founded 2018 · IPO 2021 Unicorn
Valuation
$822M
Market cap · Mar/2026
Global footprint
Where Ventyx Biosciences has talent and traffic
Web traffic by country
9.2K
monthly visits
across markets
across markets
🇺🇸 United States53.3%
🇬🇧 United Kingdom19.6%
🇮🇳 India9.8%
🇨🇦 Canada7.6%
🇳🇴 Norway6.5%
Patent intelligence
$10M patent portfolio · 10 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$10M
1.2% of market cap · 51.1× smaller than top peer ChemoCentryx ($524M)
10 active patent families
Where Ventyx Biosciences innovates
DiseaseMedicinal chemistryPharmacologyHeterocyclic compoundDitazole
Below peer median on Legal, Strategic, Market
Quality vs same-sector peers
Ventyx Biosciences on the five Patsnap quality dimensions
Ventyx Biosciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Ventyx Biosciences concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Ventyx Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Ventyx Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.